Icure Pharmaceutical Incorporation (175250) — Capital Reinvestment Ratio
Icure Pharmaceutical Incorporation (175250) has a Capital Reinvestment Ratio of 38.07x as of June 2020, meaning it reinvests 38% of its operating cash flow (₩195.44 Million) in capital expenditures (₩7.44 Billion). Check 175250 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Icure Pharmaceutical Incorporation Capital Reinvestment Ratio (2017–2017)
This chart tracks Icure Pharmaceutical Incorporation's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Icure Pharmaceutical Incorporation (175250) cash flow conversion.
Annual Capital Reinvestment Ratio for Icure Pharmaceutical Incorporation (2017–2017)
Year-by-year Capital Reinvestment Ratio for Icure Pharmaceutical Incorporation from 2017 to 2017. See cash generation quality of Icure Pharmaceutical Incorporation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 9.02x | ₩1.12 Billion | ₩10.10 Billion | — |